Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Draft Genome Sequences of 53 Genetically Distinct Isolates of Bordetella bronchiseptica Representing 11 Terrestrial and Aquatic Hosts.

Register KB, Ivanov YV, Jacobs N, Meyer JA, Goodfield LL, Muse SJ, Smallridge WE, Brinkac L, Kim M, Sanka R, Harvill ET, Losada L.

Genome Announc. 2015 Apr 23;3(2). pii: e00152-15. doi: 10.1128/genomeA.00152-15.

2.

Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity.

Place DE, Muse SJ, Kirimanjeswara GS, Harvill ET.

PLoS One. 2014 Sep 8;9(9):e107188. doi: 10.1371/journal.pone.0107188. eCollection 2014.

3.

Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission.

Rolin O, Muse SJ, Safi C, Elahi S, Gerdts V, Hittle LE, Ernst RK, Harvill ET, Preston A.

Infect Immun. 2014 Feb;82(2):491-9. doi: 10.1128/IAI.01260-12. Epub 2013 Oct 14.

4.

Resident microbiota affect Bordetella pertussis infectious dose and host specificity.

Weyrich LS, Feaga HA, Park J, Muse SJ, Safi CY, Rolin OY, Young SE, Harvill ET.

J Infect Dis. 2014 Mar;209(6):913-21. doi: 10.1093/infdis/jit597. Epub 2013 Nov 13.

5.

A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo.

Weyrich LS, Rolin OY, Muse SJ, Park J, Spidale N, Kennett MJ, Hester SE, Chen C, Dudley EG, Harvill ET.

PLoS One. 2012;7(10):e45892. doi: 10.1371/journal.pone.0045892. Epub 2012 Oct 12.

6.

Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice.

Zhang X, Goel T, Goodfield LL, Muse SJ, Harvill ET.

J Immunol. 2011 Apr 15;186(8):4895-904. doi: 10.4049/jimmunol.1000594. Epub 2011 Mar 11.

Supplemental Content

Support Center